University of Texas Health Science Center at Houston — Biomedical Watch V2

Essais liés7clinical trials

VilleHoustonlocalisation

PaysUnited Stateslocalisation

SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT05069558

Ouvrir le site du centre

Essais cliniques associés

7

Molécule	Indication / population	Phase	NCT	Titre	Statut
AFSW Guided DOAC	Accident vasculaire cérébral	Phase 3	NCT05836987	REACT-AF — The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation	RECRUITING
Investigational PFO Closure Device	Accident vasculaire cérébral	Non applicable	NCT05069558	OCCLUFLEX — Comparing PFO Outcomes of the Occlutech Flex II PFO Occluder to Standard of Care PFO Occlusion	ACTIVE_NOT_RECRUITING
A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications	Parkinson	À vérifier	NCT07330258	A US Study That Observes How Parkinson's Disease Changes Over Time in Patients Who Still Have Movement Symptoms Despite Taking Parkinson's Medications	RECRUITING
Intravenously administered pooled human immunoglobulin (IVIG)	Myopathies	Phase 2	NCT06599697	The MIGHT Trial - An Exploratory Clinical Trial of IVIG in Anti-HMGCR Immune Mediated Necrotizing Myopathy	RECRUITING
Receipt of the Minder System (implantable sub-scalp continuous electroencephalographic (EEG) monitoring (iCEM) system)	Épilepsie	Non applicable	NCT07110337	DETECT — Diagnosing Epilepsy To EffeCT Change	RECRUITING
Litifilimab	Lupus	Phase 2/3	NCT05531565	AMETHYST — A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus	ACTIVE_NOT_RECRUITING
PIPE-307 Dose A	SEP	Phase 2	NCT06083753	VISTA — Study to Evaluate the Safety and Efficacy of PIPE-307 in Subjects With Relapsing-Remitting Multiple Sclerosis	COMPLETED